Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - TOTAL CURRENT LIABILITIES
Total Current Liabilities REGN - Regeneron Pharmaceuticals, Inc.
3.94 B
LAST VALUE
1.23%
2 YEAR CAGR
17.11%
5 YEAR CAGR
20.32%
10 YEAR CAGR